ELIFE HLDGS Announces Departure of Two Executive Directors Following AGM Resolution Failure

Stock News
Aug 25

ELIFE HLDGS (00223) has issued a formal announcement regarding changes to its board composition, effective immediately after the company's annual general meeting.

According to the company statement, the resolutions to re-elect Ms. Zhang Qixuan, Ms. Feng Minshan, Mr. Lin Qiucheng, and Mr. Wang Anxin were not approved at the shareholders' annual general meeting. As a result, ELIFE HLDGS (00223) confirmed that Ms. Zhang Qixuan and Ms. Feng Minshan have officially stepped down from their positions as executive directors, while Mr. Lin Qiucheng and Mr. Wang Anxin have also retired from their roles as independent non-executive directors.

Following her departure, Ms. Zhang Qixuan will no longer serve as a member of the company's nomination committee or as the chairperson of the investment and strategy committee. In a similar vein, Mr. Lin Qiucheng's retirement means he has relinquished his positions on the audit committee, nomination committee, and investment and strategy committee, in addition to stepping down as the chairperson of the remuneration committee. Furthermore, Mr. Wang Anxin has ceased to be a member of the audit committee, remuneration committee, and investment and strategy committee, and has also given up his role as the chairperson of the nomination committee.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10